Jennifer Patterson

Dr. Jennifer Patterson

IMDEA Materials Institute
+1
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 September 2010 in Biomaterials
Verified
Journal Article
Closed access
Jennifer PattersonJennifer Patterson
Jennifer Patterson
RSRuth Siew
Ruth Siew
SHSusan W. Herring
Susan W. Herring
ALAngela S.P. Lin
Angela S.P. Lin
RGRobert Guldberg
Robert Guldberg
PSPatrick S. Stayton
Patrick S. Stayton

28 September 1999 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MWMichael W. West
Michael W. West
WWWeixun Wang
Weixun Wang
Jennifer PattersonJennifer Patterson
Jennifer Patterson
JMJoseph D. Mancias
Joseph D. Mancias
JBJames R. Beasley
James R. Beasley
MHMichael H. Hecht
Michael H. Hecht
Amyloid deposits are associated with several neurodegenerative diseases, including Alzheimer’s disease and the prion diseases. The amyloid fibrils isolated from these different diseases share similar structural features. However, the protein sequences that assemble into these fibrils differ substantially from one disease to another. To probe the relationship between amino acid sequence and the propensity to form amyloid, we studied a combinatorial library of sequences designed de novo . All sequences in the library were designed to share an identical pattern of alternating polar and nonpolar residues, but the precise identities of these side chains were not constrained and were varied combinatorially. The resulting proteins self-assemble into large oligomers visible by electron microscopy as amyloid-like fibrils. Like natural amyloid, the de novo fibrils are composed of β-sheet secondary structure and bind the diagnostic dye, Congo red. Thus, binary patterning of polar and nonpolar residues arranged in alternating periodicity can direct protein sequences to form fibrils resembling amyloid. The model amyloid fibrils assemble and disassemble reversibly, providing a tractable system for both basic studies into the mechanisms of fibril assembly and the development of molecular therapies that interfere with this assembly.

1 January 2010 in Materials Today
Verified
Journal Article
Open access
Jennifer PattersonJennifer Patterson
Jennifer Patterson
MMMikaël M. Martino
Mikaël M. Martino
JHJeffrey A. Hubbell
Jeffrey A. Hubbell


1 May 2019 in Acta Biomaterialia
Verified
Journal Article
Closed access
AKAbhijith Kudva
Abhijith Kudva
ADAnna D. Dikina
Anna D. Dikina
FLFrank P. Luyten
Frank P. Luyten
Eben AlsbergEben Alsberg
Eben Alsberg
Jennifer PattersonJennifer Patterson
Jennifer Patterson